Inventor · disambiguated record
George Weiner
Also filed as: WEINER GEORGE · WEINER GEORGE J
13 granted patents·11 pending applications·1,141 citations·filing 1995–2025
93Inventor score
Files withUNIV IOWA RES FOUND15PROTEIN DESIGN LABS INC3CHECKMATE PHARMACEUTICALS INC2PDL BIOPHARMA INC1SALEM ALIASGER K1
Top patents by PatentIndex Score
24 records- 0197US6218371B1Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokinesUNIV IOWA RES FOUND·Filed 1999·Granted Apr 17, 2001·755 cites·23 claims
- 0295US7534772B2Methods for enhancing antibody-induced cell lysis and treating cancerUNIV IOWA RES FOUND·Filed 2001·Granted May 19, 2009·70 cites·4 claims
- 0393US7381803B1Humanized antibodies against CD3PDL BIOPHARMA INC·Filed 2000·Granted Jun 3, 2008·74 cites·9 claims
- 0492US6129914ABispecific antibody effective to treat B-cell lymphoma and cell linePROTEIN DESIGN LABS INC·Filed 1995·Granted Oct 10, 2000·195 cites·28 claims
- 0590US7723036B2Assessing response to anti-CD20 therapy by genotyping C1q componentsUNIV IOWA RES FOUND·Filed 2006·Granted May 25, 2010·12 cites·12 claims
- 0681US9730988B2Parasitic biological agents for treatment and prevention of graft versus host diseaseUNIV IOWA RES FOUND·Filed 2015·Granted Aug 15, 2017·3 cites·20 claims
- 0781US6512096B2Prostate cell surface antigen-specific antibodiesUNIV IOWA RES FOUND·Filed 2001·Granted Jan 28, 2003·17 cites·28 claims
- 0873US12195744B2Identification of T-cell trafficking genes and uses thereof for increasing infiltration of T-cells into solid tumorsUNIV IOWA RES FOUND·Filed 2018·Granted Jan 14, 2025·1 cites·14 claims
- 0970US9572894B2Biodegradable particulate formulationsSALEM ALIASGER K·Filed 2011·Granted Feb 21, 2017·2 cites·5 claims
- 1068US10314854B2Methods for treating tumors in situ including intratumor injection of cytotoxic particles and immune checkpoint blockade therapyUNIV IOWA RES FOUND·Filed 2016·Granted Jun 11, 2019·1 cites·20 claims
- 1159US12246031B2Compositions and methods for tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2019·Granted Mar 11, 2025·0 cites·5 claims
- 1258US10934549B2Nucleic acid aptamersUNIV IOWA RES FOUND·Filed 2018·Granted Mar 2, 2021·0 cites·17 claims
- 1358US2004052783A1Humanized antibodies against CD3PROTEIN DESIGN LABS INC·Filed 2003·Application pending·0 cites
- 1457US2008025975A1Humanized antibodies against cd3PROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 1556US2021180067A1Nucleic acid aptamersUNIV IOWA RES FOUND·Filed 2021·Application pending·0 cites
- 1656US2024182568A1Methods of enhancing antibody therapiesUNIV IOWA RES FOUND·Filed 2022·Application pending·0 cites
- 1755US6207805B1Prostate cell surface antigen-specific antibodiesUNIV IOWA RES FOUND·Filed 1998·Granted Mar 27, 2001·11 cites·17 claims
- 1855US2025255898A1Compositions and methods for tumor immunotherapyCHECKMATE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1953US2007071717A1Treatment of B cells with IL-21 and B cell activators induces Granzyme B productionUNIV IOWA RES FOUND·Filed 2006·Application pending·0 cites
- 2053US2005197314A1Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokinesUNIV IOWA RES FOUND·Filed 2005·Application pending·0 cites
- 2152US2007191262A1Cancer Therapy and Prevention Based on Modulation of Complement activityUNIV IOWA RES FOUND·Filed 2006·Application pending·0 cites
- 2249US2003072762A1Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance Fc receptor-mediated immunotherapiesFiled 2002·Application pending·0 cites
- 2347US2002064515A1Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokinesFiled 2001·Application pending·0 cites
- 2443US2006115834A1Methods of identifying metastatic potential in cancerUNIV IOWA RES FOUND·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George Weiner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →